SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike S1 (RBD) Recombinant Protein

Produktübersicht

• Artikelname: SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike S1 (RBD) Recombinant Protein
• Artikelnummer: BYT-ORB1231047
• Hersteller Artikelnummer: orb1231047
• Alternativnummer: BYT-ORB1231047-50
• Hersteller: Biorbyt
• Kategorie: Proteine/Peptide
• Alternative Synonym: 2019-nCoV Spike Protein S1 (RBD), Spike Receptor Binding Domain Variant United Kingdom, 501Y.V1, covid-19, sars-cov-2

Produktbeschreibung

SARS-CoV-2 (COVID-19) Alpha Variant (B.1.1.7, UK) Spike S1 (RBD) Recombinant Protein

Produkteigenschaften

• Konzentration: 1mg/ml after reconstitution.
• Molekulargewicht: ~60kDa (SDS-PAGE)
• NCBI: 43416
• UniProt: P0DTC2
• Puffer: Lyophilized. Contains PBS.
• Reinheit: 95% (SDS-PAGE)
• Formulierung: Lyophilized
• Sequenz: Receptor-binding domain (RBD) of SARS-CoV-2 Spike protein S1 (aa 319-541) containing the mutation N501Y is fused to the N-terminus of the Fc region of human IgG1.
• Target-Kategorie: S

Anwendungsbeschreibung

• Anwendungsbeschreibung: Biological Activity: Binds to human ACE2

Bilder

SARS-CoV-2 Spike Protein S1 (RBD):Fc (human) (rec.) (B.1.1.7 Variant, UK) binds to the receptor ACE2 (human) (rec.) slightly stronger than SARS-CoV-2 Spike Protein S1 (RBD):Fc (human) (rec.) (WT).